HomeAI · summaries
Storia in 2 fonti
United Therapeutics Corporation Announces FDA Approval of the LungFX™ Device for Centralized Ex Vivo Lung Perfusion
United Therapeutics Corporation Announces FDA Approval of the LungFX™ Device for Centralized Ex Vivo Lung Perfusion
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
morningstar.com
United Therapeutics Corporation Announces FDA Approval of the LungFX™ Device for Centralized Ex Vivo Lung Perfusion
United Therapeutics Corporation Announces FDA Approval of the LungFX™ Device for Centralized Ex Vivo Lung Perfusion
- ·
benzinga.com
FDA Approval Positions United Therapeutics To Broaden Access To Donor Lungs - United Therapeutics (NASDAQ
United Therapeutics received FDA approval for LungFX, a device designed to expand donor lung use in transplantation.